155 related articles for article (PubMed ID: 34109109)
1. Effect of 1α,25-Dihydroxyvitamin D3 on the Radiation Response in Prostate Cancer: Association With IL-6 Signaling.
Wu CT; Huang YC; Chen WC; Chen MF
Front Oncol; 2021; 11():619365. PubMed ID: 34109109
[TBL] [Abstract][Full Text] [Related]
2. Role of vitamin D3 in tumor aggressiveness and radiation response for hepatocellular carcinoma.
Chen PT; Hsieh CC; Chen MF
Mol Carcinog; 2022 Aug; 61(8):787-796. PubMed ID: 35611989
[TBL] [Abstract][Full Text] [Related]
3. 1α,25-Dihydroxyvitamin D3 Inhibits Esophageal Squamous Cell Carcinoma Progression by Reducing IL6 Signaling.
Chen PT; Hsieh CC; Wu CT; Yen TC; Lin PY; Chen WC; Chen MF
Mol Cancer Ther; 2015 Jun; 14(6):1365-75. PubMed ID: 25824337
[TBL] [Abstract][Full Text] [Related]
4. The role of IL-6 in the radiation response of prostate cancer.
Wu CT; Chen MF; Chen WC; Hsieh CC
Radiat Oncol; 2013 Jun; 8():159. PubMed ID: 23806095
[TBL] [Abstract][Full Text] [Related]
5. Apoptosis is induced by the active metabolite of vitamin D3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: possible implications for prevention and therapy.
Díaz GD; Paraskeva C; Thomas MG; Binderup L; Hague A
Cancer Res; 2000 Apr; 60(8):2304-12. PubMed ID: 10786699
[TBL] [Abstract][Full Text] [Related]
6. Role of interleukin-6 in the radiation response of liver tumors.
Chen MF; Hsieh CC; Chen WC; Lai CH
Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):e621-30. PubMed ID: 22975618
[TBL] [Abstract][Full Text] [Related]
7. 1alpha, 25-dihydroxyvitamin D3 suppresses interleukin-8-mediated prostate cancer cell angiogenesis.
Bao BY; Yao J; Lee YF
Carcinogenesis; 2006 Sep; 27(9):1883-93. PubMed ID: 16624828
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D inhibition of prostate adenocarcinoma growth and metastasis in the Dunning rat prostate model system.
Getzenberg RH; Light BW; Lapco PE; Konety BR; Nangia AK; Acierno JS; Dhir R; Shurin Z; Day RS; Trump DL; Johnson CS
Urology; 1997 Dec; 50(6):999-1006. PubMed ID: 9426741
[TBL] [Abstract][Full Text] [Related]
9. A combined pretreatment of 1,25-dihydroxyvitamin D3 and sodium valproate enhances the damaging effect of ionizing radiation on prostate cancer cells.
Gavrilov V; Leibovich Y; Ariad S; Lavrenkov K; Shany S
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):391-4. PubMed ID: 20214985
[TBL] [Abstract][Full Text] [Related]
10. 1α,25-Dihydroxyvitamin D3 Regulates Mitochondrial Oxygen Consumption and Dynamics in Human Skeletal Muscle Cells.
Ryan ZC; Craig TA; Folmes CD; Wang X; Lanza IR; Schaible NS; Salisbury JL; Nair KS; Terzic A; Sieck GC; Kumar R
J Biol Chem; 2016 Jan; 291(3):1514-28. PubMed ID: 26601949
[TBL] [Abstract][Full Text] [Related]
11. Prostate derived factor in human prostate cancer cells: gene induction by vitamin D via a p53-dependent mechanism and inhibition of prostate cancer cell growth.
Lambert JR; Kelly JA; Shim M; Huffer WE; Nordeen SK; Baek SJ; Eling TE; Lucia MS
J Cell Physiol; 2006 Sep; 208(3):566-74. PubMed ID: 16741990
[TBL] [Abstract][Full Text] [Related]
12. 1α,25-dihydroxyvitamin D3 inhibits cell growth and NFκB signaling in tamoxifen-resistant breast cancer cells.
Lundqvist J; Yde CW; Lykkesfeldt AE
Steroids; 2014 Jul; 85():30-5. PubMed ID: 24747771
[TBL] [Abstract][Full Text] [Related]
13. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
14. UVB-induced conversion of 7-dehydrocholesterol to 1alpha,25-dihydroxyvitamin D3 in an in vitro human skin equivalent model.
Lehmann B; Genehr T; Knuschke P; Pietzsch J; Meurer M
J Invest Dermatol; 2001 Nov; 117(5):1179-85. PubMed ID: 11710930
[TBL] [Abstract][Full Text] [Related]
15. The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer.
Chen TC; Schwartz GG; Burnstein KL; Lokeshwar BL; Holick MF
Clin Cancer Res; 2000 Mar; 6(3):901-8. PubMed ID: 10741714
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of vitamin D analogs as therapeutic agents for prostate cancer.
Chen TC; Holick MF; Lokeshwar BL; Burnstein KL; Schwartz GG
Recent Results Cancer Res; 2003; 164():273-88. PubMed ID: 12899529
[TBL] [Abstract][Full Text] [Related]
17. Wavelength-dependent induction of CYP24A1-mRNA after UVB-triggered calcitriol synthesis in cultured human keratinocytes.
Bär M; Domaschke D; Meye A; Lehmann B; Meurer M
J Invest Dermatol; 2007 Jan; 127(1):206-13. PubMed ID: 16902422
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of prostate cancer growth by vitamin D: Regulation of target gene expression.
Krishnan AV; Peehl DM; Feldman D
J Cell Biochem; 2003 Feb; 88(2):363-71. PubMed ID: 12520538
[TBL] [Abstract][Full Text] [Related]
19. 1,25-dihydroxyvitamin D3 inhibits corneal wound healing in an ex-vivo mouse model.
Sel S; Trau S; Paulsen F; Kalinski T; Stangl GI; Nass N
Graefes Arch Clin Exp Ophthalmol; 2016 Apr; 254(4):717-24. PubMed ID: 26794222
[TBL] [Abstract][Full Text] [Related]
20. Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3.
Skowronski RJ; Peehl DM; Feldman D
Endocrinology; 1995 Jan; 136(1):20-6. PubMed ID: 7530193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
